Homocysteine Biochemistry and Cognitive Decline in the Elderly

Journal of the American Medical Directors Association

Volumn 18, Issue 10, 2017, Pages 893-894

  Gostner, Johanna ^a   Sperner Unterweger, Barbara ^a   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; NEOPTERIN; NEUROTRANSMITTER; SEROTONIN; TRYPTOPHAN; BIOLOGICAL MARKER; CARBON;

AGED; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CELL METABOLISM; COGNITION; COGNITIVE DEFECT; ENTERIC FEEDING; FOLLOW UP; FRAILTY; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LETTER; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; VITAMIN SUPPLEMENTATION;

AGED; BIOMARKERS; CARBON; COGNITIVE DYSFUNCTION; HOMOCYSTEINE; HUMANS; VITAMIN B 12;

EID: 85028299383     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2017.06.029     Document Type: Letter

References (19)

1. Mendonça, N., Granic, A., Mathers, J.C., et al. One-carbon metabolism biomarkers and cognitive decline in the very old: The Newcastle 85+ Study. J Am Med Assoc Dir 18 (2017), 806.e19–806.e27.
2. Schroecksnadel, K., Grammer, T.B., Boehm, B.O., et al. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemostas 103 (2010), 926–935.
3. Frick, B., Gruber, B., Schroecksnadel, K., et al. Homocysteine but not neopterin declines in demented patients on B vitamins. J Neural Transm 113 (2006), 1815–1819.
4. Bleie, Ø., Semb, A.G., Grundt, H., et al. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med 262 (2007), 244–253.
5. Løland, K.H., Bleie, O., Blix, A.J., et al. Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: A Western Norway B Vitamin Intervention Trial (WENBIT) substudy. Am J Cardiol 105 (2010), 1577–1584.
6. Ploder, M., Schroecksnadel, K., Spittler, A., et al. Moderate hyperhomocysteinemia in patients with multiple traumas and with sepsis predicts poor survival. Mol Med 16 (2010), 498–504.
7. Schroecksnadel, K., Frick, B., Wirleitner, B., et al. Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Clin Exp Immunol 134 (2003), 53–56.
8. Schroecksnadel, K., Wirleitner, B., Winkler, C., Fuchs, D., Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364 (2006), 82–90.
9. Frick, B., Schroecksnadel, K., Neurauter, G., et al. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem 37 (2002), 684–687.
10. Solichova, D., Melichar, B., Blaha, V., et al. Biochemical profile and survival in nonagenarians. Clin Biochem 34 (2001), 563–569.
11. Schroecksnadel, K., Leblhuber, F., Frick, B., et al. Association of hyperhomocysteinemia in Alzheimer disease with elevated neopterin levels. Alzheimer Dis Assoc Disord 18 (2004), 129–133.
12. Pedersen, E.R., Midttun, Ø., Ueland, P.M., et al. Systemic markers of interferon-γ-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol 31 (2011), 698–704.
13. Murr, C., Grammer, T.B., Kleber, M.E., et al. Low serum tryptophan is associated with immune activation, inflammation and predicts mortality in patients with cardiovascular disease, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur J Clin Invest 45 (2015), 247–254.
14. Strasser, B., Gostner, J.M., Fuchs, D., Mood, food, and cognition: Role of tryptophan and serotonin. Curr Opin Clin Nutr Metab Care 19 (2016), 55–61.
15. Walter, R.B., Fuchs, D., Weiss, G., et al. HMG-CoA reductase inhibitors are associated with decreased serum neopterin levels in stable coronary artery disease. Clin Chem Lab Med 41 (2003), 1314–1319.
16. Schroecksnadel, K., Winkler, C., Wirleitner, B., et al. Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin Exp Immunol 140 (2005), 41–45.
17. Capuron, L., Schroecksnadel, S., Féart, C., et al. Chronic low grade immune activation in the elderly is associated with increased tryptophan catabolism and altered phenylalanine turnover: Role in neuropsychiatric symptomatology. Biol Psych 70 (2011), 175–182.
18. McIntyre, R.S., Lee, Y., Cognition in major depressive disorder: A Systemically Important Functional Index (SIFI). Curr Opin Psychiatry 29 (2016), 48–55.
19. Marcos-Péreza D, Sánchez-Flores M, Maseda A, et al. Frailty status in older adults is related to alterations in indoleamine 2,3-dioxygenase 1 and guanosine triphosphate cyclohydrolase 1 enzymatic pathways. J Am Med Dir Assoc 2017 http://dx.doi.org/10.1016/j.jamda.2017.06.021. [Epub ahead of print].